Safety and Immunogenicity of Norovirus Bivalent Virus-Like Particle Vaccine in Healthy Adults
NCT02142504
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
454
Enrollment
INDUSTRY
Sponsor class
Conditions
Norovirus Prevention
Interventions
BIOLOGICAL:
Norovirus Bivalent VLP Vaccine
DRUG:
Placebo (Saline)
Sponsor
Takeda